Rheumnow Podcast
Dr. Cush
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Mentioned books
Jan 27, 2023 • 28min
Simon Says “Don’t Do This” (1.27.2023)
Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything
Jan 20, 2023 • 19min
The RheuNow Podcast Preview - Til Death Do Us Part (1.20.2023)
Dr. Jack Cush reviews the highlights from the past week on RheumNow.com
Jan 13, 2023 • 23min
Rheum Believe it Or Not (1.13.2023)
Dr. Jack Cush reviews the notable standouts in the news since the 1st of January. Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.
Jan 6, 2023 • 25min
RheumNow Podcast- 2022 Rheumatology Year in Review
Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology
Check out the full podcast at RheumNow.com
Dec 16, 2022 • 22min
Fever, FROST, & Pericarditis (12.16.2022)
Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.
Dec 9, 2022 • 21min
Biosimilar Bonanza in 2023 (12.9.2022)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Dec 2, 2022 • 21min
Rheum Manpower Needs - More Programs! (12.2.2022)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Dec 1, 2022 • 22min
Biologics in Lupus – Why, Who, and When? Sponsored by GSK US Medical Affairs
Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.
Nov 20, 2022 • 54min
Topic Podcasts - JAK_TYK2
ACR22 Year in Review Report
Deucravacitinib in PsA
JAK inhibitors in rheumatic diseases
JAK vs TNF inhibitor Infections in RA
New Treatments for SLE?
Prelude to a Meeting (ACR22) (11.11.2022)
Switching Between JAK Inhibiters in RA
Tapering Methotrexate with Biologics or JAK Inhibitors in RA
Tofacitinib and RA-ILD
Upadacitinib vs Adalimumab in PsA using RAPID3
Nov 20, 2022 • 1h 5min
Topic Podcasts - Lupus Part3
Addressing Sexual Health and STD Prevention in Lupus Patients
CAR-T Therapies in Antiphospholipid Antibody Syndrome
Copays Reduce Adherence to SLE Medications
Diffuse alveolar hemorrhage in antiphospholipid syndrome
Hydroxychloroquine Update from ACR22
Low-grade Proteinuria in Non Renal Lupus: Should We be Worried?
Photovoice: A New Visual Research Method in Lupus
Stop Ordering Repeat ANAs!
Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies
Life or Organ Threatening SLE: What To Do? Is There Anything New?
